J Cancer
2022; 13(14):3595-3597.
doi:10.7150/jca.79561 This issueCite
Erratum
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum
Zhongqing Zou1,2#, Tingting Guo1,3#, Jian Cui1, Wenjiao Tang1, Yan Li1, Fangfang Wang1,4, Tian Dong1, Yunfan Yang1, Yan Feng1, Matthew Ho5, Li Zhang1 , Ling Pan1, Ting Niu1
1. Department of Hematology, West China Hospital, Sichuan University, China. 2. Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China. 3. Center for Precision Medicine, West China Hospital, Sichuan University, China. 4. Hematology Research Laboratory, Department of Hematology, West China Hospital, Sichuan University, China. 5. Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States. #These authors contributed equally to this study.
✉ Corresponding author: Li Zhang, Department of Hematology, West China Hospital, Sichuan University. No.37 Guoxue Lane, Wuhou District, Chengdu 610041, China. E-mail: drzhangli2014com; Tel.: 86-28-189 806 066 90.
Citation:
Zou Z, Guo T, Cui J, Tang W, Li Y, Wang F, Dong T, Yang Y, Feng Y, Ho M, Zhang L, Pan L, Niu T. Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum. J Cancer 2022; 13(14):3595-3597. doi:10.7150/jca.79561. https://www.jcancer.org/v13p3595.htm
The authors recently noticed a mistake in the initially published version of our article. When combining different images into Figure 2, an identical image of R-ISS, shown at upper left in Figure 2A, was selected as the middle image at the lower line in Figure 2B. The corrected Figure 2 and the corresponding figure legend are provided below. The error does not alter any results and conclusions of this study. All authors agree to the erratum and regret any inconvenience that it may have caused.
Figure 2
(A) PFS and OS among patients with newly diagnosed MM according to RISS(a, c), genetic abnormalities(b, d). (B) Univariable significant risk factors were Men(a), Age <65(b), extramedullary multiple myeloma (EMM) of initial diagnosis(c), high ECOG score(d), R-ISS score(Figure 2A-a) and +1q 21 (e) for PFS. (C) Univariable significant risk factors were high ECOG score(a), LDH(b) and P53 deletion (c) for OS.
Author contact
Corresponding author: Li Zhang, Department of Hematology, West China Hospital, Sichuan University. No.37 Guoxue Lane, Wuhou District, Chengdu 610041, China. E-mail: drzhangli2014com; Tel.: 86-28-189 806 066 90.
Published 2022-11-3
Citation styles
APA
Zou, Z., Guo, T., Cui, J., Tang, W., Li, Y., Wang, F., Dong, T., Yang, Y., Feng, Y., Ho, M., Zhang, L., Pan, L., Niu, T. (2022). Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum. Journal of Cancer, 13(14), 3595-3597. https://doi.org/10.7150/jca.79561.
ACS
Zou, Z.; Guo, T.; Cui, J.; Tang, W.; Li, Y.; Wang, F.; Dong, T.; Yang, Y.; Feng, Y.; Ho, M.; Zhang, L.; Pan, L.; Niu, T. Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum. J. Cancer 2022, 13 (14), 3595-3597. DOI: 10.7150/jca.79561.
NLM
Zou Z, Guo T, Cui J, Tang W, Li Y, Wang F, Dong T, Yang Y, Feng Y, Ho M, Zhang L, Pan L, Niu T. Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum. J Cancer 2022; 13(14):3595-3597. doi:10.7150/jca.79561. https://www.jcancer.org/v13p3595.htm
CSE
Zou Z, Guo T, Cui J, Tang W, Li Y, Wang F, Dong T, Yang Y, Feng Y, Ho M, Zhang L, Pan L, Niu T. 2022. Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum. J Cancer. 13(14):3595-3597.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.